In order to implement the strategic deployment of Hunan's strong province of traditional Chinese medicine and the requirements of Hunan's plan to build a national comprehensive reform demonstration zone for traditional Chinese medicine, strengthen the development and industrial extension of authentic medicinal materials resources in the province, and actively create the business sector of traditional Chinese medicine resources, from May 18th to 21st, under the leadership of Cai Xinya, member of the Party Committee, Vice General Manager, and Chairman of Xingxiang Group, and Wang Ziling, Minister of Xingxiang Group's Strategic Investment Department, the company's traditional Chinese medicine resource inspection team went deep into Changde City and Yongzhou City to gain a detailed understanding of local traditional Chinese medicine resources, cultivation, and industrial development. They also reached preliminary intentions on cooperation in local traditional Chinese medicine cultivation, processing, procurement, and extended development. The main leaders of Changde Rural Agriculture Bureau and Yongzhou Science and Technology Bureau, as well as the relevant district and county-level leaders under the two cities, received and inspected the visit.

From May 18th to 21st, the inspection team conducted on-site inspections of medicinal herb planting bases in Dingcheng District, Hanshou County, Lengshuitan District, and Lingling District of Changde City, and conducted preliminary cooperation discussions on product development and sales of Hunan Xingchen Biotechnology Co., Ltd. and cooperation in the traditional Chinese medicine extract industry of Hunan Hill Natural Pharmaceutical Co., Ltd.

Based on the selected key cooperative varieties and the local Chinese herbal medicine industry planning and policy support direction, the company has reached a preliminary cooperation intention with the local government. Firstly, the company will cooperate with qualified professional planting cooperatives in the local area, sign long-term procurement agreements, and utilize the company's advantages in medicinal material production and processing to strengthen the reserve and purchase of medicinal materials that meet quality requirements; The second is to build "customized medicinal gardens" in the two cities through a "joint construction as the main approach and self construction as a supplement", jointly build medicinal planting bases, expand the scale of medicinal planting, and strengthen standardized planting; Thirdly, we will focus on the deep processing of traditional Chinese medicinal materials and the development of comprehensive health products; Fourth, relying on hospitals, with the help of emerging technologies such as "Internet plus" and "Internet of Things", we will pilot the construction of Chinese medicine sharing, dispensing and distribution centers in the two cities to provide medical institutions and patients in the two cities with "full dosage, personalized, one-stop" solutions for efficient and safe supply of high-quality Chinese medicine products; The fifth is to rely on the company's industry university research platform with Hunan University of Traditional Chinese Medicine and Hunan Provincial Institute of Traditional Chinese Medicine, as well as its own R&D strength, to utilize the company's new production line capacity release, promote the research and development of traditional Chinese medicine and its derivative products, and enhance product added value.